BOSTON and JERUSALEM, Jan. 30, 2017 /CNW/ -- DarioHealth Corp. (NASDAQ: DRIO), based in Boston and Jerusalem, focused on digital health and mobile health solutions, today announced that Erez Raphael, Chairman & CEO, will present live at VirtualInvestorConferences.com on February 2, 2017.
DATE: Thursday, February 2, 2017
TIME: 10:45 AM
This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the association's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.
It is recommended that investors pre-register and run the online system check to save time and receive event updates.
Learn more about the event at www.VirtualInvestorConferences.com.
Recent Company Highlights
- Deal led by OurCrowd Qure, a dedicated digital health fund that invested $2.5 million of the $5.1 million.
- Current investors of DarioHealth also participated in the current round indicating the strong support and belief in the company's strategy moving forward.
- OurCrowd Qure granted two board seats, which will be selected and announced at a later date.
- Funding will be used to accelerate adoption across existing markets and into new geographies such as Germany in 2017.
- $2 million of gross proceeds are subject to shareholder approval per NASDAQ rules.
About DarioHealth Corp.
DarioHealth is a leader in digital health self-management solutions. DarioHealth delivers the ability to combine and analyze consumer health data to personalize treatment and advance medical knowledge. Dario's™ smart diabetes management solution is a platform for diabetes management that combines the Dario™ Blood Glucose Monitoring System all-in-one blood glucose meter, native smart phone app, website portal and a wide variety of treatment tools to support more proactive and better informed decisions by users living with diabetes, their doctors and healthcare systems. Having recently launched in the largest market in the world for glucose monitoring, U.S. sales are expected to have a significant impact on revenues and gross margins. With marketing clearance in Europe and the U.S., the Dario iOS mobile app recently launched with reimbursement in the United Kingdom, Australia, Israel, Italy, and Canada, and has also launched in New Zealand, Netherlands, Italy, and Belgium.
For more information, visit http://mydario.investorroom.com/http://mydario.investorroom.com/
Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.
SOURCE DarioHealth Corp.
To view this news release in HTML formatting, please use the following URL: http://www.newswire.ca/en/releases/archive/January2017/30/c3653.html
For further information: DarioHealth Corp., DarioHealth Corporate and Media Contact, Shmuel Herschberg, Marketing Director, firstname.lastname@example.org, 1-800-896-9062; DarioHealth Investor Relations Contact, Hayden IR, Rob Fink / Brett Maas, DRIO@HaydenIR.com, 646-415-8972 / 646-536-7331, VirtualInvestorConferences.com; Bradley H. Smith, Director of Marketing, IR and Compliance Services, PR Newswire, +1.201.947.7157, email@example.com, https://mydario.com